Dupilumab in Moderate-to-Severe Atopic Dermatitis: Pooled Efficacy Results from Two Identically Designed Randomized Phase 3 Trials (SOLO 1 & 2)

Main Article Content

Carlos Ferrandiz
Pablo de la Cueva Dobao
Eric L Simpson
Rick Zhang
Abjijit Gadkari
Laurent Eckert
Bolanle Akinlade
Marius Ardeleanu

Keywords

dupilumab, randomized trial, atopic dermatitis

Abstract

Abstract Not Available